Midkine
Midkine (9-23) is a synthetic peptide fragment corresponding to amino acids 9 through 23 of the human midkine protein, a heparin-binding growth factor involved in diverse physiological and pathological processes. As a bioactive peptide, this sequence segment has garnered interest for its role in mediating cellular signaling, neurodevelopment, and tissue repair mechanisms. The unique structural and functional properties of this peptide make it a valuable tool for dissecting the molecular actions of midkine and for exploring its interactions with cellular receptors, extracellular matrix components, and downstream intracellular pathways. Researchers utilize Midkine (9-23) to probe the biological significance of midkine's N-terminal region, offering insights into its contribution to cell proliferation, migration, and survival.
Receptor binding studies: One of the principal applications of Midkine (9-23) lies in its use as a molecular probe for investigating midkine receptor interactions. This peptide fragment encompasses a region critical for binding to cell surface receptors such as anaplastic lymphoma kinase (ALK) and low-density lipoprotein receptor-related proteins (LRPs). By employing the peptide in ligand-receptor assays, researchers can delineate binding affinities, map interaction sites, and elucidate the structural determinants necessary for midkine-mediated signaling. Such studies are essential for clarifying the mechanistic basis of midkine's biological activity and for identifying potential targets for modulating its function in vitro.
Cell signaling pathway analysis: The peptide is frequently employed to dissect intracellular signaling cascades activated by midkine. By introducing Midkine (9-23) into cultured cells, investigators can selectively trigger or inhibit specific pathways, including those regulating cell growth, differentiation, and survival. Monitoring downstream effectors—such as MAPK, PI3K/Akt, or STAT pathways—enables a detailed understanding of how this region of midkine influences cellular responses. These experiments provide a controlled approach to studying the functional consequences of midkine-receptor engagement, independent of the full-length protein.
Neurobiology and neuroprotection research: Midkine (9-23) has been adopted in neurobiological studies to explore its effects on neuronal growth, synaptic plasticity, and neuroprotection. The peptide's ability to mimic or modulate native midkine activity allows researchers to examine its influence on neurite outgrowth, cell adhesion, and survival under stress conditions. Such applications are particularly relevant in models of neural development, injury, or degeneration, where the peptide can help elucidate mechanisms underlying neuronal resilience and repair.
Extracellular matrix interaction assays: The heparin-binding domain within the 9-23 region enables the peptide to serve as a model system for studying midkine's interactions with glycosaminoglycans and other extracellular matrix components. By incorporating it into binding assays or cell adhesion experiments, scientists can assess how this segment contributes to matrix association, cell migration, and tissue organization. These insights are valuable for understanding the broader role of midkine in tissue morphogenesis and remodeling.
Peptide-based inhibitor screening: Due to its defined sequence and functional relevance, Midkine (9-23) is also used as a template for screening and developing peptide-based inhibitors or mimetics. Researchers utilize the peptide in competitive binding assays to evaluate candidate molecules that disrupt midkine-receptor or midkine-matrix interactions. Such studies facilitate the identification of novel modulators for further research on midkine signaling pathways and their implications in cell biology and disease models.
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More